Sign In
|
Register
|
About Menlo Park
|
Contact Us
Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast
|
Traffic
Menlo Park News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Menlo Park Gas Prices
Ski And Snow Reports
Financial Markets
Bagels
Bakery
Barbecue
Burgers
Chinese
Coffee House
Continental
Deli
Fast Food
French
Ice Cream / Frozen Yogurt
International
Italian
Japanese
Mexican
Pizza
Sandwiches
Seafood
Steak Chops
Sushi
Wine
Bars and Lounges
Museum
Family Fun
Arts & Culture
Parks
Annual Events
Golf
Accommodations
Bed and Breakfast
Hotel and Motel Management
Hotels & Resorts
Apartments
Apartment Finding & Rentals
Apartments
Art & Culture
Galleries & Dealers
Museums
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Non-Profits
Professional & Trade Associations
Attractions & Entertainment
Activities
Amusement & Water Parks
Biking
Events & Festivals
Horseback Riding
Movie Theatres
Automotive
Auto Detail
Dealers - New
Dealers - Used
Mobile Home Dealers
Parts & Supplies
Repair & Service
Tires
Towing
Window Tinting and Repair
Beauty & Fitness
Beauty Salons
Cosmetics
Fitness Equipment & Apparel
Fitness Programs
Health Clubs & Gyms
Health Services & Home Health
Manicures
Massage
Personal Trainers
Piercing & Tattoo
Plastic Surgeons
Skin Treatment
Tanning Salons
Weight Loss
Yoga
Business & Professional Services
Billing Services
Bookkeeping Service
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Courier, Delivery & Messenger Service
Data Processing Service
Employment Services, Placement & Agencies
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Industrial
Internet Services
Marketing & Advertising Services
Media Services
Notary Services
Office Furniture, Equipment & Supplies
Office Supplies
Photography
Printing & Publishing
Public Relations & Publicity
Screen Printing
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Translators & Interpreters
Video Production
Waste Management & Recycling
Commercial Contractors
Contractors
Architects
Building Contractors & Consultants
Concrete
Drywall, Plastering & Insulation
Electric
Fences and Gates
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Roofing
Special Trade Contractors
Domestic Services
Child Care Services
Housecleaning
Pet Sitting and Day Care
Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment Agencies
Financial Services
Accountants & Tax
Banks & Credit Unions
Escrow Services
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Mortgage Lenders
Golf
Government
City & County Government
Federal Government
State Government
Hair Salons
Health and Medicine
Alternative Medicine / Acupuncture
Chiropractors
Counseling
Dentistry
Dermatologists
Drug Stores & Pharmacies
Emergency Services
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Medical Doctors
Medical Equipment & Supplies
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Appliances
Bed & Bath
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Closets
Contractors
Doors, Windows & Drapery
Floor Coverings
Furniture
Glass
Handyman
Heating, Cooling & AC
Home Improvement Centers
Interior Design & Decorating
Kitchen
Lamps & Lighting
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Patios & Decks
Pest Control
Plumbing
Pools, Spas & Saunas
Sewage & Septic Systems
Tools
Insurance
Agents & Brokers
Health
Home
Life
Laser Hair Removal
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Audio & Visual
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Industrial Supplies & Services
Machine Shops
Metal
Plastics
Textiles & Apparel
Media
Television Stations
Meeting & Event Planning
Event Facilities
Party Rentals & Entertainment
Miscellaneous
Nightlife
Bars and Lounges
Personal Service
Car Wash
Child Care
Dry Cleaning and Laundry
Shoe Repair
Tailors and Alterations
Pets
Pet Boarding & Kennels
Pet Shops
Pet Supplies & Food - Retail
Veterinary Hospitals
Plastic Surgery
Plastic Surgeon
Real Estate
Appraisers
Assisted Living & Elder Care Service
Commercial
Condominiums
Developers
Property Management
Real Estate Agents and Brokers
Residential
Schools
Religion
Relocation
Movers
Storage
Restaurants
Bakery
Barbecue
Burgers
Chinese
Coffee Houses
Continental
Deli
Fast Food
French
Ice Cream / Frozen Yogurt
International
Italian
Japanese
Mexican
Pizza
Sandwiches
Seafood
Steaks, Chops
Sushi
Wine
Shopping
Accessories
Antiques
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Convenience Stores
Department Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Grocery Stores
Health Food Stores
Home Improvement
Jewelry
Men's Clothing Stores
Pharmacies
Resale Shops
Shoe Stores
Shopping Centers & Malls
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Day Spas
Resort Spas
Sports & Recreation
Associations & Clubs
Bicycles
Dance Clubs & Studios, Instruction
Equestrian
Gymnastics
Health Clubs
Instruction
Martial Arts
Race Tracks
Recreation Facilities
Tennis
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
Internet Advertising & Services
Semiconductor
Software
Travel & Transportation
Airlines & Airports
Auto Rentals
Bus Lines & Charters
Hotels & Resorts
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Bridal Shops
Cakes & Caterers
Photographers & Videographers
Your Business Here
Apartments
Buyer Information
Seller Information
About Steve
REO
Short Sales
Relocation
Mortgage Information
Danville Communities
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Menlo Park
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
131.19
+0.31 (+0.24%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Merck’s WELIREG® (belzutifan) Significantly Improved Progression-Free Survival and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
October 21, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck’s KEYTRUDA® (pembrolizumab) Plus Concurrent Chemoradiotherapy Significantly Improved Progression-Free Survival (PFS) Versus Concurrent Chemoradiotherapy Alone in Newly Diagnosed, High-Risk Locally Advanced Cervical Cancer
October 20, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck & Company Inc. (NYSE: MRK) Highlighted for Surprising Price Action
October 05, 2023
Via
Investor Brand Network
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Statistically Significant Improvement in Pathological Complete Response (pCR) Rate as Neoadjuvant Therapy Versus Chemotherapy in High-Risk, Early-Stage ER+/HER2- Breast Cancer
October 20, 2023
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy Significantly Improved Progression-Free Survival (PFS) Versus Trastuzumab and Chemotherapy in First-Line HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
October 20, 2023
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After Surgery Reduced Risk of Death by 28% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)
October 20, 2023
From
Merck & Co., Inc.
Via
Business Wire
Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs
October 19, 2023
From
Daiichi Sankyo
Via
Business Wire
Merck Receives Positive EU CHMP Opinion for PREVYMIS® for Prevention of CMV Disease in High-Risk Adult Kidney Transplant Recipients and Extended 200-Day Dosing in Adult HSCT Recipients at Risk for Late CMV Infection and Disease
October 17, 2023
From
Merck & Co., Inc.
Via
Business Wire
FDA Approves KEYTRUDA® (pembrolizumab) for Treatment of Patients With Resectable (T≥4 cm or N+) NSCLC in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as a Single Agent as Adjuvant Treatment After Surgery
October 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults With Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
October 16, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)
October 13, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease
October 10, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Announces Pivotal KEYNOTE-671 Trial Meets Dual Primary Endpoint of Overall Survival (OS) in Resectable Stage II, IIIA or IIIB Non-Small Cell Lung Cancer (NSCLC)
October 10, 2023
From
Merck & Co., Inc.
Via
Business Wire
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
October 06, 2023
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.
Via
MarketBeat
Merck’s KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery
October 05, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck to Hold Third-Quarter 2023 Sales and Earnings Conference Call Oct. 26
October 05, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Receives Priority Review from FDA for New Biologics License Application for Sotatercept, an Activin Signaling Inhibitor to Treat Adults with Pulmonary Arterial Hypertension (PAH)
September 28, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Patients With Certain Types of Metastatic Non-Small Cell Lung Cancer
September 22, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Announces Phase 3 KEYNOTE-A39/EV-302 Trial Met Dual Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
September 22, 2023
From
Merck & Co., Inc.
Via
Business Wire
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
September 20, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress...
Via
FinancialNewsMedia
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Concurrent Chemoradiotherapy as Treatment for Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer
September 20, 2023
From
Merck & Co., Inc.
Via
Business Wire
FDA Accepts for Priority Review Merck’s Supplemental New Drug Application for WELIREG® (belzutifan) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)
September 19, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adults with Non-Small Cell Lung Cancer at High Risk of Recurrence Following Complete Resection and Platinum-Based Chemotherapy
September 15, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)
September 11, 2023
From
Merck & Co., Inc.
Via
Business Wire
European Commission Expands Merck’s ERVEBO® [Ebola Zaire Vaccine, (rVSVΔG-ZEBOV-GP) live] Indication to Include Children 1 Year of Age and Older
September 07, 2023
From
Merck & Co., Inc.
Via
Business Wire
Long-Term Follow-up Data on Sustained Immunogenicity and Safety for GARDASIL®9 Published in Pediatrics
September 05, 2023
From
Merck & Co., Inc.
Via
Business Wire
Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Merck & Co., Inc.
Via
Business Wire
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)
August 29, 2023
From
Merck & Co., Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Events
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.